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Abstract
A biological pathway represents a set of genes that serves a particular cellular or a
physiological function. The genes within the same pathway are expected to function
together and hence may interact with each other. It is also known that many genes,
and so pathways, interact with other environmental variables. However, no formal
procedure has yet been developed to evaluate the pathway-environment interaction. In
this article, we propose a semiparametric method to model the pathway-environment
interaction. The method connects a least square kernel machine and a semiparametric
mixed effects model. We model nonparametrically the environmental effect via a nat-
ural cubic spline. Both a pathway effect and an interaction between a pathway and
an environmental effect are modeled nonparametrically via a kernel machine, and we
estimate variance component representing an interaction effect under a semiparametric
mixed effects model. We then employ a restricted likelihood ratio test and a score test
to evaluate the main pathway effect and the pathway-environment interaction. The
approach was applied to a genetic pathway data of Type II diabetes, and pathways with
either a significant main pathway effect, an interaction effect or both were identified.
Other methods previously developed determined many as having a significant main
pathway effect only. Furthermore, among those significant pathways, we discovered
some pathways having a significant pathway-environment interaction effect, a result
that other methods would not be able to detect.
Keywords: environmental variable; Gaussian random process; Kernel machine; Path-
way analysis; Semiparametric model; Smoothing splines
Running Title: Semiparametric Method for Evaluating Pathway-Environment Inter-
action
1 Introduction
Gene-related diseases are complex processes associated not only with specific gene or gene
sets but also with gene-gene and gene-environment interaction. For decades, statistical
methods have focused on analyzing microarray data based on single genes or single-nucleotide
polymorphisms (SNPs) analysis (Chatterjee et al., 2006; Hahn et al., 2003; Maity et al., 2009;
Moore et al., 2010; Ritchie et al., 2001). However, single-gene based methods have many
limitations. For instance, the effect of one gene on a disease is difficult to interpret and
current methods are unable to model gene dependencies so that they may not detect genes
with moderate changes that give more insight into biological processes but pick up single
gene with dramatic changes (Mootha et al., 2003). For these reasons, gene-set or pathway-
based approaches have attracted increasing attention in recent years (Goeman et al., 2004,
2005; Liu et al., 2007; Wang, et al., 2007; Pang et al., 2006, 2011; Kim et al, 2011). It is
recognized that a joint study of the association between the outcome and a group of genes
within the same pathway could complement genes/SNPs analysis for providing insight in
understanding complex diseases (Wang, et al., 2007).
A genetic pathway is the interactions of genes that depend on each other’s individual
functions and act accordingly to create the aggregate function related to a cellular process
(Goeman et al., 2004). There are several special characteristics of pathways, such as various
dimensionality (a pathway can contain several genes or over a thousand ones), and inter-
action network (genes within the a pathway are expected to function together and hence
interact with each other). Thus traditional statistical analyses face difficulties in handling
these situations. For instance, linear parametric models usually either fail due to the “curse
of dimensionality”, or end up with computational explosion in the number of possible in-
teractions among genes within a pathway. To deal with these difficulties, many innovative
statistical methods have merged in recent years. Goeman et al. (2004) proposed a global
3
test derived from a random effects model to determine the significance of the global ex-
pression pattern of a group of genes. A random forests approach was proposed by Pang
et al. (2006). Liu et al. (2007) proposed a semiparametric model for covariate and genetic
pathway effects on continuous outcomes, where the covariate effects and the pathway effect
are modeled parametrically and nonparametrically, respectively. They established the con-
nection between the least squares kernel machine (LSKM) and linear mixed models, which
simplifies specification of a nonparametric model with multi-dimensional data. Pang et al.
(2011) considered more complicated situations with two or more pathway effects presented
in the linear mixed model, which allows the researcher to study how multiple pathways relate
to the phenotype of interest. A semiparametric Bayesian approach has also been proposed
for evaluating pathway effects on clinical outcomes Kim et al (2011). However, despite the
success of analyzing pathways instead of a single gene, all existing methods ignore the envi-
ronment exposure covariates, and still fewer focus on the interaction between environmental
variables and the genetic pathways.
It has been recognized that genetic factors alone cannot account for many cases of gene
related disease (Adami, et al., 2008; Chakravarti and Little, 2003). The gene-environment
(G-E) or pathway-environment (P-E) interactions are critical in understanding the dynamic
process of disease since ignoring them may mask the detection of a genetic effect and may
lead to inconsistent association results (Manolio et al., 2006). Furthermore, understand-
ing the G-E interactions can be important for risk prediction and evaluating the benefit
of changes in modifiable environmental exposures or environmental regulations. For these
reasons, the number of studies utilizing gene-environment interactions has increased dra-
matically. These range from semiparametric linear or logistic regression models with linear
combinations of genes/SNPs as the predictor (Chatterjee et al., 2006; Maity et al., 2009;
Park and Hastie, 2008) to the multifactor dimensionality reduction (MDR) as a data mining
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technique for identifying genetic and environmental effects associated with either dichoto-
mous or continuous phenotypes (Ritchie et al., 2001; Hahn et al., 2003; Moore et al., 2010).
Unfortunately, these studies are all genes/SNPs based methods, and they possess problems
in dealing with the pathway analysis. For example, representing the pathway effects with
linear combinations of genes has limitations in detecting non-linear patterns of interacting
genes. Furthermore, the number of genes in a pathway can be in the hundreds or thousands,
which makes modeling the gene-gene or gene-environment interaction very consuming.
To capture high order interactions within the high dimensional genes regressor space as
well as the G-E interactions, Zou et al. (2010) employed a nonparametric regression model
with a Gaussian process. With their model the gene and environmental variables are modeled
non-parametrically, and all of the possible interactions effects are considered simultaneously.
However, using one Gaussian process to describe both gene and environmental variable
function spaces results in all the interaction effect being indistinguishable. Thus it is almost
impossible to apply a suitable test for interesting effects such as G-E interaction.
In this paper, we propose a semiparametric mixed effects model to include environmen-
tal variables, genetic pathway effect, and their interaction. By extending Liu et al. (2007)’s
linear mixed model to our model, we evaluate the interaction between an environmental vari-
able and pathway as well as allow nonlinear relationships between the environmental variable
and a continuous outcome. Assuming that both the pathway and interaction effects have
multivariate normal distributions with a zero mean and covariance structure with specific
kernels, we model them within the framework of Gaussian processes. Thus in our model both
pathway and interaction effects are indeed modeled as random effects. Instead of modeling
the environmental variable as a parametric fixed effect, we model it non-parametrically via
natural cubic spline. By modeling environmental variables and pathways in this way, we can
construct the kernel for the P-E interaction based on the analysis-of-variance-like (ANOVA-
5
like) decompositions of functions (Wahba, 1990; Gu and Wahba, 1993) for a multivariate
function. The feature of our method is to model the interaction between environmental and
pathway covariates separately from the interactions among genes within the pathway, which
are automatically modeled by the Gaussian process for pathway effect. Our model also ex-
tends the additive and interaction smoothing splines for univariate functions to multivariate
functions with arbitrary kernel.
In a mixed model, the smoothing parameters of the spline and the Gaussian kernels can
be considered as the variance components of the random effects, and thus are simultane-
ously estimated by maximizing the restricted maximum likelihood (REML). By additively
modeling the multivariate functions, this model is suitable for analyzing genetic pathway
data in which the P-E interaction attracts particular interests. Furthermore, the covariance
structure of our model makes the test of the “overall” pathway effect or P-E interaction
effect possible. By “overall” we mean either the main effect of a pathway, the interaction
effect associated with the pathway, or both. The restricted likelihood ratio test (RLRT) of
two zero variance components under non-standard conditions is employed to test the overall
pathway effect, while the RLRT of one zero-variance component and score test are applied
to test the P-E interaction.
We first define our model in Section 2, and discuss two REML methods to estimate
the model parameters in Section 3. Then in Section 4, we introduce PLRT statistics for
testing two or one zero-variance components and the score test for testing the P-E interaction
effect. In Section 5, we present a set of simulation studies concerning nonparametric function
estimates and variance component tests for various settings. In Section 6 we apply our
method to the genetic pathway data for Type II diabetes. Finally, in the last Section, we
conclude our work and discuss potential extensions of our model.
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2 Construction of Semiparametric Linear Mixed Ef-
fects Models
2.1 Model Description and the Kernel of the Interaction Function
Space
Let us consider that we have a total of n subjects and the ith subject has a continuous
disease-related outcome yi, i = 1, 2, ...n. We are interested in relating this response y =
(y1, y2, ..., yn)
T with one particular pathway gene expression data Z = (z1, z2, ...,zn)
T and k
environmental variables. In a general form, we can write this nonlinear relationship as
y = f + , (1)
where  and f are n × 1 dimensional vectors with a specific relationship with y for the ith
entry as yi = f(x
T
i , z
T
i ) + i, in which x
T
i = (xi1, xi2, ..., xik) is 1× k vector of environmental
variables and zTi = (zi1, zi2, ..., zip) is the 1 × p vector of gene expression within a pathway
and p is the gene number. In this paper, we only consider the case with one environmental
variable, i.e., k = 1 so that the input xT is reduced to univariate x. We assume that the
errors  ∼ N(0, σ2I) are n× 1 iid random variables vector. f(·) denotes the unknown non-
linear smooth functions for xi, z
T
i , and their interaction. In this paper, we assume function
f has the following form:
f(x, zT ) = β0 + fx(x) + fz(z
T ) + fxz(x, z
T ), (2)
where β0 is the intercept term, and fα, α ∈ {x, z, xz}, represents the nonlinear effect of the
environmental variable, the pathway or the interaction respectively. The above equation is
similar to the additive model with two univariate variables and their interaction, except zT
is a multivariate variable. By writing the general model (1) in this way, we can estimate
fx, fz and their interaction fxz separately according to the characteristics of the pathway
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and the environmental variable. We model fx(x) using the nonparametric function such as
a cubic smoothing spline (Wahba, 1990; Lin and Zhang, 1999; Zhang and Lin, 2003). To
handle the high dimensional pathway covariates, zT , we may consider a Gaussian process to
express fz(z
T ) since the least squares kernel machine method with the Gaussian kernel has
achieved success in a genetic pathway data analysis (Liu et al., 2007).
Before we derive the specific representation for the interaction function, we need examine
the function space of fx and fz respectively. For the smoothing spline x ∈ T = [0, 1], fx is
spanned on the function space Hx = H0x
⊕H1x, where “⊕”, H0x and H1x represent the direct
sum operator of two subspaces, the null function space and the penalized function space
respectively (Wahba, 1990). Assuming n distinct values of xi such that 0 < x
0
1 < · · · < x0n <
1, the mth order smoothing spline estimator fx(x) can be expressed as (Wahba, 1990; Zhang
and Lin, 2003),
fx(x) =
m∑
j=1
bjφj(x) +
n∑
i=1
cikx(x, x
0
i ),
where φj(x) is the polynomial basis that span the null space H0x with φj(x) = xj−1/(j −
1)!, j = 1, 2, . . . ,m, and kx(x, x
0
i ) = [(m − 1)!]−2
∫
(x − u)m−1+ (x0i − u)m−1+ du is the kernel
which uniquely determines the space H1x. For m = 2, the natural cubic spline that we shall
apply in our model, the kernel of H1x can be calculated as (Hastie et al., 2009; Rasmussen
and Williams, 2006)
kx(x, x
′) =
∫ 1
0
(x− u)+(x′ − u)+du = min(x, x
′)3
3
+
min(x, x′)2|x− x′|
2
, (3)
where subscript “+” indicates the positive part of the expression. For the null space H0x, the
kernel is calculated as k0x(x, x
′) =
∑2
j=1 φj(x)φj(x
′) = 1 + xx′.
With the orthonormal polynomial basis, H0x = {1}
⊕{x}, where {1} and {x} stand for
the linear function spaces spanned by the constant 1 and the linear basis x which is centered
(Guo, 2002). Since the kernel of the function space of the direct sum of two subspaces is
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expressed by the direct sum of the kernel of the subspaces (Aronszajn, 1950; Wahba, 1990),
we can derive the kernel of the function space without the the constant term for the cubic
smoothing spline, {x}⊕H1x, as [xx′ + kx(x, x′)].
For the function space of fz, we consider a similar argument by MacKay (1998) that
starting from a parametric model, we can span the function of fz by a radial basis
fz(z
T ) =
H∑
h=1
chφh(z
T ), (4)
where φh(z
T ) = exp
[
−‖z−zh‖2
2ρ
]
is the radial basis functions centered at fixed points {zh}Hh=1.
Assuming c = (c1, ..., ch)
T ∼ N(0, τzI), the entry of the covariance matrix of fz is expressed
as
R = τz
∑
h
φh(z)φh(z
′).
Taking as an example a one-dimensional case, MacKay (1998) shows that in the above
expression the sum over h becomes an integral when taking the limit H → ∞ such that
R = τz exp [−(z − z′)2/ρ]. Generalizing from this particular case, we can define the Gaussian
kernel of the function space H1z on z
kz
(
zT , z′T
)
= exp
(−‖z − z′‖2/ρ) , (5)
and we assume that fz is generated from a zero mean Gaussian process with the kernel
matrix produced by kz.
Since the tensor product of the kernels of two function spaces determines a new function
space (Aronszajn, 1950), we use the tensor product of the kernels of {x}⊕H1x and H1z to
construct a new function space, H1xz, which contains any order interaction fxz between x and
zT . Now we can express the kernel of the interaction function space as
kxz
(
x, zT ;x′, z′T
)
= [xx′ + kx(x, x′)] · kz
(
zT , z′T
)
. (6)
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Therefore, we are able to represent the nonparametric interaction function using a zero mean
Gaussian process with the kernel matrix produced by this kernel function.
In the rest of this paper, we use Kx, Kz and Kxz to stand for the Gram or kernel matrices
produced by kx, kz and kxz respectively. In a specific problem, the environmental variable x
must be scaled into T = [0, 1] to construct the interaction kernel. Notice the model expression
(2) is not the analysis of variance (ANOVA) decomposition of the smoothing function f since
H1z and H1xz are not orthogonal to each other. This may cause the identifiability problem
between fz and fxz. However, in practice, this problem only happens to our model in extreme
situations such as when the entries of matrix xx′+kx(x, x′) are close to each other. In general,
fz and fxz can be identified well as shown in the simulation and application study.
2.2 Linear Mixed model Representation
Now we are prepared to pose the optimization problem. Based on the above argument,
the corresponding function spaces that are penalized are H1x, H1z and H1xz. Analogous to
the additive models (Hastie and Tibshirani, 1990), the estimation problem for model (1)
becomes: for a given set of predictors (xi, z
T
i ), i = 1, 2, ..., n, find f to maximize
− 1
2
(y − f)T (y − f)− 1
2
∑
α
λα‖fα‖2H1α , (7)
where ‖fα‖H1α ’s are the norms induced by Kα of H1α, α ∈ {x, z, xz}, and λα’s are the penalty
parameters that balance the tradeoff between goodness-of-fit and smoothing of the curve or
high dimensional surface. The solutions to expression (7) are called the least square kernel
machine estimation, and Liu et al. (2007) showed the equivalence of the least square kernel
machine to the linear mixed model without interaction effects.
The model (2) can be represented in terms of a mixed model as follows. According to
the Representer Theorem (Kimeldorf and Wahba, 1971), the nonparametric function can be
expressed by the kernel, fz(·) =
∑n
i=1 aikz(·, zTi ) and fxz(·) =
∑n
i=1 bikxz(·;xi, zTi ). So the
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vectors of these functions are
fz = Kza,
fxz = Kxzb,
where ai ∈ R, bi ∈ R. Based on the properties of reproducing kernels, the squared norms of
H1z and H1xz can be expressed as
‖fz‖2H1z = aTKza = fTz K−1z fz,
‖fxz‖2H1xz = bTKxzb = fTxzK−1xz fxz.
To represent the remaining part of model (2), β0 +fx(·), we follow Lin and Zhang (1999);
Zhang et al. (1998); Green (1987); Green and Silverman (1994)’s procedure. The vector of fx,
fx (note here the constant β0 is absorbed into fx), can be expressed in terms of β = (β0, β1)
T
and (n− 2)× 1 random vector rx as
fx = Xβ +Brx (8)
for n distinct input x values, where rx ∼ N(0, τxI) and X is the design matrix of the null
space H0x spanned by the orthogonal polynomial basis, i.e., X = (1,x) and x is the n × 1
vector of centered x. B is a matrix defined as B = L(LTL)−1, where L is n × (n − 2) full
rank matrix with M = LLT . M is a penalty matrix defined by Green and Silverman (1994)
such that the squared norm of H1x,
‖fx‖2H1x =
∫ 1
0
[f ′′x (t)]
2
dt = fTxM fx = r
T
x rx.
More details to define B and M can be found in Green and Silverman (1994), Zhang et al.
(1998) and Appendix A.
Plugging those representations of square norms and fα’s back into (7), we have
−1
2
(y − f)T (y − f)− 1
2
(
λxr
T
x rx + λzf
T
z K
−1
z fz + λxzf
T
xzK
−1
xz fxz
)
.
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If we define λx = σ
2/τx, λz = σ
2/τz and λxz = σ
2/τxz, and have random vectors rz = fz, rz ∼
N(0, τzKz) and rxz = fxz, rxz ∼ N(0, τxzKxz), then the above equation is equivalent to
− 1
2σ2
(y − f)T (y − f)− 1
2τx
rTx rx −
1
2τz
rTzK
−1
z rz −
1
2τxz
rTxzK
−1
xz rxz, (9)
which is the triple penalized log likelihood function of the linear mixed model
y = f +  = Xβ +Brx + rz + rxz + . (10)
From the Bayesian point-of-view, f is interpreted as the sum of four zero-mean stationary
Gaussian processes, each with a prior covariance function ταKα (β can be viewed with
infinite variance). The vectors rz and rxz have more specific meanings as the pathway main
effect and the P-E interaction effect. Although rx does not have such a meaning, it can
be interpreted as the nonlinear contribution of the relationship of the response and the
environmental variable.
Differentiating expression (10) with respect to β and rα’s, it is easy to show that the
best linear unbiased prediction (BLUP) estimate of the random effects, given σ2 and τα’s as
fixed, is obtained from solving
XTX XTB XT XT
BTX BTB + λxI B
T BT
X B I + λz[Kz]
−1 I
X B I I + λxz[Kxz]
−1
×

β
rx
rz
rxz
 =

XTy
BTy
y
y
 . (11)
Equation (11) shows that the BLUP estimate of β and rα’s are unique if X
TX is full rank
which is usually satisfied.
2.3 Estimate Pathway and Interaction Effects
Given the fixed parameters σ2 and τα’s, the covariance of y is obtained as follows using
model (10),
Σ = Cov(y) = σ2I + τxBB
T + τzKz + τxzKxz. (12)
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Instead of solving expression (11) directly, we perform recursive steps to simultaneously
achieve the approximate expressions of β and rα’s, α ∈ {x, z, xz},
βˆ =
(
XTΣ−1X
)−1
XTΣ−1y,
rˆx =
(
BT∆−11 B + τ
−1
x I
)−1
BT∆−11 (y −Xβˆ),
rˆz =
(
∆−12 + τ
−1
z K
−1
z
)−1
∆−12 (y −Xβˆ −Brˆz),
rˆxz =
(
∆−13 + τ
−1
xz K
−1
xz
)−1
∆−13 (y −Xβˆ −Brˆx − rˆz),
(13)
where I is the (n− 2)× (n− 2) identity matrix, and ∆j, j = 1, 2, 3, are covariances for the
following distributions,
y = Xβ + 0, 0 ∼ N(0,∆0 = Σ),
y −Xβˆ = Brx + 1, 1 ∼ N(0,∆1 = σ2I + τzKz + τxzKxz),
y −Xβˆ −Brˆx = rz + 2, 2 ∼ N(0,∆2 = σ2I + τxzKxz),
y −Xβˆ −Brˆx − rˆz = rxz + ,  ∼ N(0,∆3 = σ2I).
(14)
The above expressions for βˆ and rˆα’s are all linear transformations of y; thus, their covari-
ances are easily determined using identity Cov(Ay) = ACov(y)AT = AΣAT , where A is the
transformation matrix in expressions (13).
3 REML Estimation of the Variance Components
3.1 REML Approach for Estimating Variance Components
In the previous Section, when solving the equation (11) we assume that the regularization
parameters, τx, τz and τxz, the scale parameter ρ for Gaussian processes, and the error
variance σ2 are already known. In this linear mixed model framework, we can estimate
the parameter θ = (σ2, τx, τz, τxz, ρ)
T simultaneously using restricted maximum likelihood
(REML) estimation. REML is superior to the maximum likelihood (ML) method in terms of
adjusting the small sample bias (Zhang and Lin, 2003). The REML of our model is derived
13
routinely (Harville, 1977) up to the usual additive constant
lR = −1
2
log |Σ| − 1
2
|XTΣ−1X| − 1
2
(y −Xβˆ)TΣ−1(y −Xβˆ) + c, (15)
where c is constant. Another advantage of using REML is that it accounts for the degrees-of-
freedom adjustment of replacing β with βˆ in expression (15) (Breslow and Clayton, 1993).
Taking the derivatives of (15) with respect to θ, the estimates of θ are obtained by solving
∂lR
∂σ2
= −1
2
Tr(P ) +
1
2
(y −Xβˆ)TΣ−1Σ−1(y −Xβˆ) = 0,
∂lR
∂τα
= −1
2
Tr
(
∂Σ
∂τα
P
)
+
1
2
(y −Xβˆ)TΣ−1 ∂Σ
∂τα
Σ−1(y −Xβˆ) = 0, α ∈ {x, z, xz},
∂lR
∂ρ
= −1
2
Tr
(
∂Σ
∂ρ
P
)
+
1
2
(y −Xβˆ)TΣ−1∂Σ
∂ρ
Σ−1(y −Xβˆ) = 0,
(16)
where P = Σ−1 − Σ−1X(XTΣ−1X)−1XTΣ−1, and ∂Σ
∂ρ
= τz
∂Kz
∂ρ
+ τxz
∂Kxz
∂ρ
. The 5 × 5 infor-
mation matrix I(θ) has the i, jth entry as
I(θ)ij = 1
2
Tr
(
P
∂Σ
∂θi
P
∂Σ
∂θj
)
, (17)
and the variance of θˆ can be estimated through the expression of the information matrix.
Equation (16) can be solved using an iteration method such as Fisher’s scoring method. In
practice, the sample size n may be small, for instance the Type II diabetes data contains
only 35 observations, while the model (10) includes two fixed-effect parameters and three
smoothing parameters. We may have problems with overparameterization, and it may cause
a negative estimate of the variance components based on REML. In such case, the step-
halving method can be adopted (Jennrich and Schluchter, 1986), but still the corresponding
variance component can be estimated as very close to zero.
3.2 Profile REML Approach for Estimating Variance Components
In this Section, we suggest a modification to the REML estimation of the variance com-
ponents so that the estimate of the error components always remains in the parameter
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space. This new approach makes the use of the profile restricted maximum likelihood (p-
REML). The covariance of y in expression (12) can be written as Σ = σ2Σλ, where Σλ =
(I+λ−1x BB
T +λ−1z Kz+λ
−1
xzKxz). Defining the matrix Pλ = Σ
−1
λ −Σ−1λ X(XTΣ−1λ X)−1XΣ−1λ ,
and P = Pλ/σ
2, the restricted log likelihood function (15) can be rewritten as
lR = −1
2
(n− q) log(σ2)− 1
2
|Σλ| − 1
2
log |XTΣ−1λ X| −
1
2
yTPλy
σ2
+ c, (18)
where q = 2 is the rank of X. Assuming that λα, α ∈ {x, z, xz} are known, by solving the
derivative of (18) with respect to σ2 set equal to zero, the p-REML estimator of σ2 is
σˆ2 =
yTPλy
n− q . (19)
Since PλΣλ is idempotent,
yTPλy
σ2
∼ χ2r(Pλ), where r(Pλ) = Tr(Pλ) is the rank of Pλ, the
variance of Var(σˆ2) ≈ 2σˆ4Tr(Pλ)/(n − q)2. Plug σˆ2 back into expression (18) and we have
the log profile restricted likelihood (PRL) function
lPR = −1
2
log |Σλ| − 1
2
|XTΣ−1λ X| −
n− q
2
log(yTPλy) + c. (20)
Now we can use the similar scoring algorithm to estimate θ∗ = (λ−1x , λ
−1
z , λ
−1
xz , ρ). By simple
algebra the score of the p-REML likelihood is
∂lPR
∂θ∗j
= −1
2
Tr
(
∂Σλ
∂θ∗j
Pλ
)
+
1
2σˆ2
yTPλ
∂Σλ
∂θ∗j
Pλy, j = 1, 2, 3, 4, (21)
and the i, jth entry of the information matrix I∗(θ∗) for the PRL can be approximated as
I∗(θ∗)ij = 1
2(n− q)
{
(n− q − 2)Tr
(
∂Σλ
∂θ∗i
Pλ
∂Σλ
∂θ∗j
Pλ
)
− Tr
(
∂Σλ
∂θ∗i
Pλ
)
Tr
(
∂Σλ
∂θ∗j
Pλ
)}
. (22)
Note that I∗(θ∗) is positive definite when n is large enough. Claeskens (2004) also showed the
convergence of I∗(θ∗) under regular conditions so that we can apply the restricted likelihood
ratio test (RLRT, see Section 4). Since PRL is not a true likelihood, we only use PRL
for statistical test purposes, and use p-REML to obtain a better estimate of the variance
components. The variances of θ is found by plugging the p-REML estimates into (17).
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4 Test for Pathway Effects
4.1 Test for Two Zero Variance Components
One of the primary problems in the study of pathway based analysis is testing the “overall”
pathway effects. Recall that the meaning of “overall” refers to either the main effect of a
pathway, the interaction effect associated with the pathway, or both. In model (10), two
random effects are involved with the overall pathway effects. Thus, the hypothesis for testing
the overall pathway effect is
H0 : τz = τxz = 0 vs. Ha : τz > 0 or τxz > 0, (23)
which is equivalent to the following test
H0 : λ
−1
z = λ
−1
xz = 0 vs. Ha : λ
−1
z > 0 or λ
−1
xz > 0. (24)
For this type of test problem, a likelihood ratio test (LRT) is most commonly used. Note
that parameter space for θ = (λ−1x , λ
−1
z , λ
−1
xz , ρ)
T equals [0,∞)3 × (0,∞) (to avoid abuse
of notation, in this Section, θ and I stand for counterparts of PRL). The true parameters
θ0 are either in the interior or on the boundary of the parameter space, so the LRT is
nonstandard. Vu and Zhou (1997) generalized the hypothesis test for both interior and
boundary problems within a setting of mixed regression fitting, so it allows the nonidentically
distributed response variable yi’s to depend on the covariates and allows the random effects
to induce dependence between the response values. (Claeskens, 2004) further extended the
non-standard LRT test to the profile restricted likelihood ratio test (RLRT), focusing on
nonparametric mixed models with spline fitting.
Following (Claeskens, 2004), we apply RLRT to test hypothesis (24). Under this hypoth-
esis, the RLRT test statistics, D, is the deviance of two times the log PRL, −2lPR(θ), i.e.
D = 2lPR(θ)− 2lPR(θ0). Note that D is the same using either lR or lPR. Assuming that the
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corresponding regular conditions in Vu and Zhou (1997) are satisfied for the PRL function
model, D converges to
D → inf
θ∈C˜0
‖U − θ‖2 − inf
θ∈C˜
‖U − θ‖2, (25)
where C˜ = {θ˜ : θ˜ = I(θ0)T/2(θ − θ0),θ ∈ CΩ} is the orthonormal transformation of the
cone approximation, CΩ, of the parameter space Ω with θ0 as the vertex, and C˜0 = {θ˜ :
θ˜ = I(θ0)T/2(θ − θ0),θ ∈ CΩ0} is the orthonormal transformed cone approximation of the
parameter space Ω0 under the null hypothesis. U is a random vector from N(0, I), and
I(θ0)T/2 is the right Cholesky square root of p-REML information matrix, i.e. I(θ0) =
[I(θ0)]1/2 [I(θ0)]T/2.
Note that under the null hypothesis, θ0 = (λ
−1
x , 0, 0, ρ)
T , ρ is inestimable. We suggest
estimating the parameters with ρ fixed at the average of ‖z − z′‖2 (average on pairwise
observations) to not only reduce the parameter space dimensions but also achieve a better
fit. Let θ = (λ−1x , λ
−1
z , λ
−1
xz )
T = (θ1, θ2, θ3)
T . Now the cone parameter spaces are reduced to
CΩ = [0,∞)3 and CΩ0 = [0,∞)× {0} × {0}. However, in this problem, all three parameters
can be on the boundaries and the orthonormal transformation for the nuisance parameter
θ1 is not invariant, which leads to a transformation for 3 dimensional space. The calculation
of (25) in a 3 dimensional space becomes considerably more difficult when the information
matrix is not diagonal. To simplify the calculation, we consider the special case that θ1 ≈ 0,
which is a reasonable consideration for the Type II diabetes data in a later Section, where
the p-REML estimates of θ1’s are very close to zero for most pathways.
Now the parameter space is reduced to 2 dimensions. Under the orthonormal transforma-
tion, the cone spaces become to C˜ = {θ : γθ3 − θ2 ≥ 0, θ3 ≥ 0}, and C˜0 = {θ : θ3 = θ2 = 0},
where γ = I˜23 · |I˜(θ0)|−1/2 is the slope of the axis θ3 after transformation as shown in Figure
1(a). To account for the fact that θ1 is estimated, I˜(θ0) is defined from the 3×3 information
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matrix I(θ0) as
I˜(θ0) =
I˜22 I˜23
I˜32 I˜33
 =
I22 I23
I32 I33
−
 I21
I31
 I−111 [I12, I13] .
From the graphic point of view, the representation of the test statistics (25) is determined
by the minimum distance of the independent normal vector U = (U2, U3)
T to θ. Under the
alternative hypothesis, the minimum distance, infθ∈C˜ ‖U − θ‖2, can be understood as the
projection of U on the cone space C˜ when U is outside of the cone. As shown in Figure
1(a), the representations of infθ∈C˜ ‖U−θ‖2 are different in the four regions of the plane with
coordinates (θ2, θ3)
inf
θ∈C˜
‖U − θ‖2 =

0 θ3 ≥ 0, γθ3 − θ2 ≥ 0, I
U22 + U
2
3 − (γU2 + U3)2/(1 + γ2) θ3 + γθ2 ≥ 0, γθ3 − θ2 < 0, II
U23 θ3 < 0, θ2 ≥ 0, III
U22 + U
2
3 θ3 + γθ2 < 0, θ2 < 0, IV.
(26)
The area proportions, (φ, 1/4, 1/4, 1/2 − φ) as in the aforementioned order, of these four
regions determine the probabilities that the vector U lies in which region, where φ =
cos−1
(
γ · (1 + γ2)−1/2) = I˜23 · (I˜22I˜33)−1/2.
Under the null hypothesis, the parameters space is reduced to the origin of the plane,
thus according to Vu and Zhou (1997)
inf
θ∈C˜0
‖U − θ‖2 = U22 + U23 .
Then the asymptotic distribution of D is the difference of the above two representations
D →

U22 + U
2
3 with probability φ, I
(γU2 + U3)
2/(1 + γ2) with probability 1/4, II
U22 with probability 1/4, III
0 with probability 1/2− φ, IV.
(27)
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Note that because U2 and U3 are independent, thus (γU2 +U3)/
√
1 + γ2 ∼ N(0, 1), and the
final approximate asymptotic distribution of D is
D ∼ φχ22 + 0.5χ21 + (0.5− φ)χ20. (28)
In this paper, we suppose limn→∞ |γ| < ∞. If limn→∞ |γ| → ∞, the representation of
infθ∈C˜ ‖U − θ‖2 is in different form (Vu and Zhou, 1997) and the asymptotic distribution of
D may be different. An additional approximation is that we obtain γ with a finite sample
size under the null hypothesis, so we assume that n is large enough that the finite γ is close
to the converged value.
4.2 Test for the P-E Interaction Effect
The RLRT for two variance components introduced above allows us to test the overall
pathway effect. Furthermore, we may be attracted to testing single variance components,
such as testing the P-E effect, given that the overall the pathway effect test is significant.
The hypothesis of this problem is
H0 : λ
−1
xz = 0 vs. Ha : λ
−1
xz > 0, (29)
which is equivalent to testing H0 : τxz = 0 vs. Ha : τxz > 0. The RLRT test statistics
d = 2lPR(θ) − 2lPR(θ0) for one variance component in semiparametric model with PRL
was also suggested by Claeskens (2004), and an exact RLRT algorithm was proposed by
Crainiceanu et al. (2005). Unfortunately, this exact RLRT method cannot apply to test
(29) for model (10). In their work, there are no random effects in the model under the
null hypothesis, thus d can be represented exactly as the form of a mixture of chi-square
distribution. On the contrary, our model (10) under the null hypothesis of (29) contains two
random effects rx and rz, which makes it impossible to represent d exactly.
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The second choice is to use the method described in the previous section using an asymp-
totic distribution. However, we need the same approximations; that is, we fix ρ and assume
that the relationship between the response and the environmental variable is almost linear,
i.e. τx ≈ 0. Then similarly, the parameters cone space is reduced to 2 dimensions. One
interesting parameter θ3 = λ
−1
xz , and one nuisance parameter θ2 = λ
−1
z , both have the true
values on the boundary. Thus, CΩ = [0,∞)× [0,∞) and CΩ0 = [0,∞)× {0}.
Under the approximations described above, the asymptotic representation of 2 times the log
PRL function under the null hypothesis is
inf
θ∈C˜0
‖U − θ‖2 = 0 · I(U2 > 0) + U22 I(U2 ≤ 0) + U23 , (30)
where I(·) is the indicator function. The representation under the alternative hypothesis is
the same as in (26), but because the cone under the null hypothesis is no longer the origin of
the (θ2, θ3) plane, infθ∈C˜0 ‖U − θ‖2 has two regions as shown by (30). Now we must divide
the plane with coordinates (θ2, θ3) into five regions and set the approximated asymptotic
representation of d as (see Figure 1(b))
d→

U23 with probability 1/4, I
U22 + U
2
3 with probability φ− 1/4, I∗
(γU2 + U3)
2/(1 + γ2) with probability 1/4, II
0 with probability 1/4, III
0 with probability 1/2− φ, IV.
(31)
Thus, we have the asymptotic distribution of d for testing θ3 = λ
−1
xz = 0 or τxz = 0
d ∼ (φ− 0.25)χ22 + 0.5χ21 + (0.75− φ)χ20, (32)
where φ is calculated through γ under hypothesis (29).
In many cases, the relationship between the response and the environmental variable is
not linear, i.e. τx is significant and not equal to 0, then we are in the 3 dimension space to
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derive the asymptotic distribution of the d, which becomes arduous. In this situation, we
adopt a score test approach based on the REML function (15) which was proposed by Lin
(1997) in a mixed model. The asymptotic distribution of the REML score may not converge
to a standard normal distribution, Zhang and Lin (2003) suggested using the scaled chi-
square approximation of the test statistics. More generally, the REML score for covariance
component τα, α ∈ {x, z, xz} of (16) can also be written as
∂lR
∂τα
=
1
2
(Py)T
∂Σ
∂τα
Py − 1
2
Tr
(
P
∂Σ
∂τα
)
,
where we used identity (y −Xβˆ)TΣ−1 = (Py)T . P can be expressed as P = Γ(ΓTΣΓ)−1ΓT
(Searle et al., 1992), where ΓT is (n − q) × n matrix with full row rank n − q (q = 2 is the
rank of X). The matrix ΓT satisfies ΓTX = 0 and ΓTy ∼ N(0,ΓTΣΓ). Thus the REML
version score test statistics can be written as
Uτα =
1
2
(Py)T
∂Σ
∂τα
Py = y˜TM y˜, (33)
where y˜ = (ΓTΣΓ)−
1
2 ΓTy with y˜ ∼ N(0, In−q), and M = 12(ΓTΣΓ)−
1
2 ΓT ∂Σ
∂τα
Γ(ΓTΣΓ)−
1
2 .
Uτα is the quadratic form of y with mean E(Uτα) =
1
2
Tr
(
P ∂Σ
∂τα
)
and variance Var(Uτα) =
Ijj, where Ijj is the corresponding entry of the information matrix (17) for the interesting
variance component of τα ∈ {τx, τz, τxz}.
Let r denote the number of non-zero eigenvalues of M , then M can be further decomposed
using the spectral decomposition as M = HΞHT =
∑r
i=1 ξihih
T
i , where H = (h1, ..., hr) is
n × r orthogonal normal matrix, i.e. hTi hj = δij, and Ξ = 〈ξi〉 is r × r diagonal matrix. It
follows that
Uτα = y˜
THΞHT y˜ =
r∑
i
ξiy˜
Thih
T
i y˜ ∼
r∑
i
ξiχ
2
1.
Therefore, under H0, the distribution of Uτα can be represented as a weighted mixture
of chi-square distribution. This is because y˜Thih
T
i y˜ ∼ χ21 since hihTi is an idempotent
matrix with rank 1. Because the calculation for ξi’s is intensive, we follow Zhang and Lin
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(2003) in using the Satterthwaite method to approximate the distribution of Uτα by a scaled
chi-square distribution κχ2ν , where κ = Ijj/2E(Uτα), and ν = 2E(Uτα)2/Ijj. Zhang and
Lin (2003) also suggested to further account for the fact that θ = (σ2, τx, τz, τxz, ρ)
T is
estimated, so that κ and ν are calculated by replacing Ijj with the efficient information
I˜jj = Ijj − IjϑI−1ϑϑ ITjϑ, where Ijϑ and Iϑϑ are the corresponding vector and matrix if we
rearrange the 5× 5 information matrix I(θ) as
I(θ) =
Ijj Ijϑ
ITjϑ Iϑϑ
 .
In this paper, we are particularly interested in testing the P-E interaction effect, i.e., τxz.
5 Simulation Study
5.1 Parameters Estimation
We carried out the simulation study to evaluate the accuracies of the estimators; 200 runs
were performed for each of the simulation scenarios. Let p denote the number of genes in
the pathway and n denote the number of observations. We considered a setup that mimics
the real diabetes pathway data with a total of 50 genes within a pathway. The true model
of the ith observations is
yi = fx(xi) + fz(z
T
i ) + fxz(xi, z
T
i ) + i, i ∼ N(0, σ2)
with nonparametric functions
fx(xi) = 5.6 + 0.1xi + cos (xipi/18) ,
fz(z
T
i ) = a · z(30)i exp
(
−0.2 ¯|z|(30)i
)
/5,
fxz(xi, z
T
i ) = b · exi/10 sin
(
z¯
(30)
i
)
cos
(
z¯
(30)
i
)
/8,
(34)
where z
(30)
i ,
¯|z|(30)i and z¯(30)i stand for
∑30
j=1 zij,
∑30
j=1 |zij|/30 and
∑30
j=1 zij/30. We sample
xi and zij(j = 1, ..., 50) from Uniform[18, 36] and N(0, 1), respectively. Furthermore, a and
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b are parameters to control the magnitude of the nonparametric functions respectively. In
this Section they are fixed at a = 1.5 and b = 2. In the true model (34), a total of 30 genes,
zi1, ..., zi30, are involved. However in a real situation, we may fit the model with extra genes
that are not involved in the true model. Thus we consider the following settings for model
(34):
Setting 1: n = 100/150, true p = 30, fitted p = 30, σ2 = 0.22,
Setting 2: n = 100/150, true p = 30, fitted p = 40, σ2 = 0.22,
Setting 3: n = 100/150, true p = 30, fitted p = 50, σ2 = 0.22.
For each setting, two sample sizes n = 100 and 150 were considered.
In Section 3 we introduced two methods to estimate the variance components using
REML and p-REML. We are particularly interested in comparing the performance of these
two methods. One of the difficulties of solving equation (16) or (21) using a scoring method is
finding the initial values for θ or θ∗, since there are no analytic expressions to roughly obtain
those initial values. Breslow and Clayton (1993) suggested starting the variance parameters
from small positive values within a complex situation. We started the variance components
with (σ2, τx, τz, τxz)
T = (0.001, 0.001, 0.001, 0.001)T , which is equivalent to starting with
(σ2, λ−1x , λ
−1
z , λ
−1
xz )
T = (0.001, 1, 1, 1) for p-REML. For scale parameter ρ, we can either fix or
estimate it. In this simulation study, we choose the initial value ρ = 2 which is the average of
‖z − z′‖2 on all pairwise observations if it is estimated. We also compare the results with ρ
fixed at 2. Note that if ρ is estimated, we consider two possible ways. One way is to perform
a two-step procedure where we first fix ρ at 2 and evaluate (σ2, τx, τz, τxz) until convergence
and then use the results with ρ = 2 as the initial values to evaluate (σ2, τx, τz, τxz, ρ) until
convergence. The other way is to evaluate (σ2, τx, τz, τxz, ρ) together from an initial value
(0.001, 0.001, 0.001, 0.001, 2)T . The simulation results show that the former method is more
stable, so only these results are shown. Similarly, a two-step procedure was used for p-REML
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when ρ is estimated.
To demonstrate the fitting results, Figure 2 shows one selected example of setting 1
comparing estimated f , fx, rz and rxz with the true ones. The overall response f is fitting
very well as shown in Figure 2(d). As shown in Figure 2(b) and (c), there is not much
identifiability issue since both the fitted pathway effect rˆz and fitted the interaction effect
rˆxz capture the patterns of the true ones very well.
To have a overall evaluation of the goodness-of-fit of the nonparametric function fx, fz
and fxz, we followed the techniques used by Liu et al. (2007), who suggested regressing the
true nonparametric functions on the fitted ones. By reporting the average intercepts, slopes
and R2’s from these regressions, the goodness-of-fit of the fitted nonparametric functions can
be assessed empirically. The closer to 0 and 1 of the intercepts and slopes are and the closer
to 1 of R2 is, the better the performance of the estimation is.
In Table 1 we summarized the goodness-of-fit of fα, α ∈ {x, z, xz} for 200 hundred runs.
The scenarios of three settings were used in four procedures: I) REML with ρ estimated, II)
REML with ρ fixed at 2, III) p-REML with ρ estimated, and IV) p-REML with ρ fixed at
2. It can be seen that the performance of using procedure I) is not so good; ρ goes to an
extremely large value and fα’s deviate from fˆα’s. This may be because the REML likelihood
function dose not have a maximum and the likelihood increases or becomes flat with ρ. In
such a case, the entries of Kz becomes a matrix of ones. One solution when the REML
function becomes flat with ρ is to fix ρ at the turning point of the REML function. In
procedure II) we fixed ρ at 2. The average of ‖z − z′‖2 on all pairwise observations is very
close to 2 and using this ρ allows us to avoid having extreme values for the entries of Kz. The
performance of this procedure is improved significantly; all the R2 values are over 90% and
close to 1, and the intercepts and slopes of the regressions are close to 0 and 1. However, σˆ2
values are all close to zero. The zero error component happens in REML estimation (Searle
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et al., 1992), especially with high dimensional parameter spaces.
Table 1 shows that the performance is much better for the two p-REML procedures. Not
only is the fitting of nonparametric functions very good, but the estimate of error variance
component σˆ2 is close to the true value. As expected, fitting with extra genes introduces more
error, which results in the increase of σˆ2. This is because fitting irrelevant genes is equivalent
to introducing more noise into the model. However, the results show little difference in fitting
fα’s for differently used gene numbers. Increasing the number of observations is expected
to improve the fitting performance. Although overall there is no much difference between
n = 100 and 150, there is slight improvement in fitting the P-E interaction effect. This can
be seen from the fact that R2 increases and the slope of regressing fxz on fˆxz is closer to 1
for n = 150.
The overall goodness-of-fit using p-RMEL is very good, except there are small biases:
the regression slope of fz on fˆz is slightly smaller than 1 and the the regression slope of fxz
on fˆxz is slightly larger than one. This means that fz is overestimated and fxz is slightly
underestimated. However, for each fz and fxz, the fitted results can explain most of the
variations as all the R2 values are very close to 1. We also realized that the fitting of fz +fxz
is much better than individual ones (the regression parameters of fz + fxz on ̂fz + fxz are
not shown), which is easy to be understood if we can treat r = rz + rxz as one random effect
with covariance τzKz+τxzKxz. This indicates that there is no bias in fitting fz+fxz, but the
weight between fz and fxz might be biased. The reason for this can be understood from the
interaction kernel expression (6). It can be seen that if the entries of matrix xx′ + kx(x, x′)
are close to each other, then τzKz + τxzKxz is nothing more than a scalar times Kz, and we
will have overestimation of fz. However, this bias is not too significant, because the good fit
of fz + fxz and the high R
2 values of fitting fxz indicate that it has little influence on testing
either the overall pathway or the P-E interaction effect.
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5.2 Test Study
To obtain better convergence, for the rest of this paper we adopt the Marquardt procedure
as a scoring method. With the Marquardt method we have flexible iteration steps, this is
θ(k+1) = θ(k) +
[
I(θ(k)) + δ(k)I
]−1 ∂lR
∂θ
∣∣∣∣
θ(k)
,
where lR, I, and θ are replaced by the counterparts of the p-REML procedure when it is
required. The scalar δ(k) partially determines the step size and I is the identity matrix. If
δ(k) is small, the procedure approximates a scoring method. If δ(k) is large, a small step is
taken in approximately the direction of the scoring method. We modify δ(k) accordingly to
achieve increasing likelihood. In this paper, we start from δ(k) = (1.0 × 10−5) × Tr(I(θ))
number of θ′is
to make the initial step size as large as possible.
We first studied the performance of RLRT of testing two zero variance components under
hypothesis (24). In this simulation study we are particularly interested in two issues: how
RLRT performs at different fixed ρ values since we prefer to estimate the parameters with
ρ fixed and how the performance degrades with irrelevant genes included in the model. The
true model used and the data generating method are the same as described for (34) in Section
5.1. For both issues, we first set a = 0 and vary b, and then set b = 0 and vary a. It turns
out the test is very powerful when both a and b are not equal to zero, so no simulation on
this situation is shown here. For all cases, the total number of simulation runs is 1000 times.
In addition, the function fx(·) in (34) has a trivial nonlinear component, so we can apply
RLRT in this simulation.
For the first issue, we consider the case where the sample size is n = 100, and both the
true and used gene numbers are p = 30. Table 2 presents the Type II errors and powers of
testing hypothesis (24) for 2 sets of {a, b} values at 4 different ρ values (one is estimated).
In general, the power curve of RLRT does not depend on ρ very much. Liu et al. (2007)
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revealed the same phenomena for the score test of a single variance component within a
model with only one random effect. This is because moderate differences of ρ do not change
the structure of the covariance matrix very much, except for extreme values such as ρ → 0
or ρ → ∞, with which the covariance matrix turns to an identity matrix or a matrix of
ones. Note that the empirical Type II errors of all situations are around 0.03, smaller than
the nominal one. The reason could be the approximation of (28) due to the assumption,
θ1 = λ
−1
x ≈ 0.
To test two zero variance components with extra genes, we consider simulations with the
sample sizes n = 60 and n = 35. The latter mimics the Type II diabetes data where the
total subjects under study are n = 35. Fitting with the equal true and used gene numbers
is compared to fitting with an extra 20 irrelevant genes. The results in Table 3 show that,
when fitting with extra genes, the power decreases as expected but not dramatically, which
means that the model we proposed can be applied to pathway data for which only some of
the genes are related to the responses. In addition, comparing Table 2 and 3 shows that the
power does decrease with the sample size n.
The simulation study for testing P-E interaction using RLRT and the score test is carried
out using a new setup for the data generation. We continue using the same nonparametric
expression (34) except with true gene number p = 5; that is, simply replacing fz(·) and fxz(·)
as fz(z
T
i ) = a · z(5)i exp
(
−0.2 ¯|z|(5)i
)
/5 and fxz(xi, z
T
i ) = b · exi/10 sin
(
z¯
(5)
i
)
cos
(
z¯
(5)
i
)
/8,
where z
(5)
i =
∑5
j=1 zij,
¯|z|(5)i =
∑5
j=1 |zij|/5 and z¯(5)i =
∑5
j=1 zij/5. xi, zij and i are generated
the same way as before. Note the function form changes when the gene number is different
in (34). We use this setup to compare two test procedures for testing (29). For the score
test, we first estimate the parameters using p-REML and then calculate the statistics using
expressions (17) and (33). The results are listed in Table 4. Again, we see that the test’s
power does not depend on ρ. The results indicate that the RLRT are slightly lower in power
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and that the type I errors of the two test methods are all closer to the nominal 5% from
different directions. These results indicate we can apply both test methods under suitable
conditions.
6 Application to Type II Diabetes Data
We applied our mixed model (10) to a set of diabetes data from Mootha et al. (2003).
They utilized the HGC-133a Affymetrix genechip with 22,283 genes to study 17 normal
glucose tolerance individuals vs. 18 Type II diabetes mellitus patients. The 22,283 genes
make up a total of 251 pathways. The goal of this study is to identify pathways with the
highest significant overall pathway effect when an environmental variable, body mass index,
is present in the model, and from them identify pathways with significant P-E interaction
effect. Therefore, there are a total of 251 sets of data, each having n = 35 observations.
Corresponding to each individual pathway, the data set contains (y, X, Z), where y is the
outcomes of glucose level, X has the same meaning as before with the first column of 1’s
and the second column as the body mass index data of 35 subjects, and Z(n× p) is the gene
expression levels of each pathway, which contains the number of genes ranging from p = 3
to p = 543.
The fitting results of the top 20 pathways are listed in Table 5 ranked ascendingly in the
p-value of testing the overall pathway effect using RLRT D. It has almost an identical order
of the magnitude as the D. It can be seen that 19 out of the 251 pathways are significant.
For each pathway, the variance components are estimated using p-REML methods and the
standard error of those parameters including σˆ2 are calculated using information matrix (17)
with the p-REML estimates plugged in. Again, the initial values for the variance parameters
are (σ2, λ−1x , λ
−1
z , λ
−1
xz )
T = (0.001, 1, 1, 1)T and ρ is fixed at the average of ‖z−z′‖2 of different
pairwise observations, which ranges from 0.1 to 1.8 for different pathways.
28
To show an overall view of the fitting results for 251 pathways, Figure 3 plots the four
estimated variance components in the same order of the p-value of RLRT D. The straight
dashed line divides the significant and insignificant pathways of RLRT. The error compo-
nents, σˆ2’s, are around the constant 3.0 except for those top significant pathways. This is
consistent with the test results indicating that for those pathways with genes relevant to the
responses, the error is reduced since part of the variation of the responses is explained by
pathway main effect or P-E interaction effect. The variations of τˆx and τˆz seems to compen-
sate for each other. For the top 50 pathways, τˆx’s are close to zero and τˆz values are large.
On the other side, for those pathways which are ranked as lower than 50, τˆz values are very
small and τˆx values increase. This indicates that for those pathways not relevant enough to
the response, part of the variation of response is explained by the nonlinear relationship of
the responses and the environmental variable. The variation of τˆxz seems less dramatic than
other random effects. It does not decrease to zero for those non significant pathways, and
stabilizes after the top 100 pathways. However, using the test of RLRT d, we show that the
lower ranked pathways, ranked as [50, ..., 251], are not significant in the interaction effect.
These results suggest that the body mass index is important in explaining the relationship
between the glucose level and the genetic pathway since many pathways that are significant
in the overall pathway effect are either significant in the interaction effect or not.
Because the distribution for D is asymptotic, the p-value calculated based on 35 observa-
tions may not be as accuracte as expected. Hence, we carried out a permutation test process
to obtain the exact distribution of D as follows:
• Step 1 : We fit the observed data with the full model (10) and reduced model under
hypothesis (24) using the p-REML approach. In both models, we set τx = 0 since we
assume that τx is insignificant when deriving (28). Then we obtained test statistics D,
and calculated the residual ˆ0 = rˆz + rˆxz + ˆ using the fitted results of the full model
29
from y = Xβ + rz + rxz + .
• Step 2 : We permuted the residual ˆ0 to get new ˆ∗0 and simulate outcomes as y∗ =
Xβˆ + ˆ∗0.
• Step 3 : Based on y∗, X and Z, we fit the full model (10) and reduced model under hy-
pothesis (23) again using the p-REML approach and then calculated the test statistics
D∗.
• Step 4 : We repeated Steps 2-3 for a large number of times (e.g. 10,000 times).
• Step 5 : We obtained the empirical p-value of the RLRT by formula p-value = (number
of D∗’s greater than D) ÷ (total number of D∗’s).
The p-value of the permutation test of D as well as the RLRT D are listed in Table 6 in
the same order of Table 5 for the top 20 pathways. Note that for RLRT if the sample size
is too small such that the information matrix (22) is non positive definite, φ in (28) cannot
be calculated, so we are not able to get the asymptotic distribution of D. However the
information matrices of the 251 pathways under hypothesis (24) are all positive definite (not
true under hypothesis (29)), so we are able to test the overall pathway effect for all using
RLRT D. The results of both tests are similar to each other with respect to the general
rank of the significance, specifically both tests have the same top 3 pathways, which are
pathways 73, 274, and 230. In addition, most of the p-values of the permutation tests are
slightly larger than those of RLRT, as expected, since the permutation test is usually more
conservative. Table 6 also labels those significant pathways ranked in the top 50 list according
to the global score test (Goeman et al., 2004) and the forest tree method Pang et al. (2006);
Pang and Zhao (2008), which do not take into account the environmental variable in their
models. Our approach identified pathways that have either significant main pathway effect,
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the interaction effect, or both, while other methods determined many as having a significant
main pathway effect only. Through following one zero variance component test, we also
discovered that some pathways have a significant P-E interaction effect although they may
not have a significant main pathway effect.
Furthermore, the p-values of RLRT d are also listed in Table 6. There are pathways for
which we are unable to calculate d because the information matrix is not positive definite.
In Figure 4 the p-values of RLRT D and RLRT d of all pathways are plotted for comparison.
Among the top 50 that are significant in overall pathway effect, only part of them are
significant in the interaction effect, but for the remaining 151 pathways, none are significant
in either interaction effect or overall pathway effect. Similar to RLRT D, a permutation test
process for the exact distribution of RLRT d is introduced here:
• Step 1 : We fit the observed data with the full model (10) and reduced model under
hypothesis (29) using the p-REML approach. Again in both models we assume that
τx is negligible. Then we obtained d, and calculated the residual ˆ0 = rˆxz + ˆ using the
fitted results of the full model from y = Xβ + rz + rxz + .
• Step 2 : We permuted the residual ˆ0 to get new ˆ∗0 and simulated outcomes as y∗ =
Xβˆ + rˆz + ˆ
∗
0.
• Step 3 : Based on y∗, X and Z, we fit the full model and reduced model under hy-
pothesis (29) again using the p-REML approach and then calculated the test statistics
d∗.
• Step 4 : We repeated Steps 2-3 a large number of times (e.g. 10,000 times).
• Step 5 : We obtained the empirical p-value of the RLRT by formula p-value = (number
of d∗’s greater than d) ÷ (total number of d∗’s).
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The permutation test results of RLRT d are close to those of RLRT d in the 20 pathways,
but it is difficult to tell which one is more conservative.
We also calculated the p-values of testing H0 (29) using the score test approach for the
top 20 pathways. Compared with the RLRT d and RLRT d permutation tests, the p-values
of the score test is similar in sense of determining the significant pathways at the 5% level.
Among these top 20 pathways with significant overall pathway effect, the pathways with
insignificant interaction effect are {229, 152, 16, 236, 144, 151, 103, 271, 101, 158} according to
the score test, and {229, 152, 16, 236, 144, 151, 14, 103, 271, 150, 158} according to the RLRT
d permutation test. Note that the difference of the two sets, {14, 101, 150}, all have marginal
p-values for the two tests at the 5% level. If they are removed from the two sets, both tests
have identical pathways which have insignificant P-E environment interaction effects.
Based on the three tests procedures, we identified the pathways with a significant
P-E environment interaction effect for all tests among the top 20 pathways. They are
{73, 274, 230, 173, 228, 172} pathways at the 5% level. These pathways are known to be
related to Type II diabetes. Pathway 73 is a Cysteine metabolism pathway. It is known that
taurine (a semi-essential sulphur amino acid) derived from cysteine metabolism can prevent
diabetes mellitus and/or insulin resistance (Franconi et al., 2006). Pathway 274 is involved in
the Urea cycle and metabolism of amino groups, which has also been reported to be related
to Type II diabetes (Czyzyk et al., 1989). Pathway 230 is OXPHOS HG-U133A probes
pathway. It has been reported that genes involved in oxidative phosphorylation are co-
ordinately upregulated with fasting hyperglycaemia in the livers of patients with Type II
diabetes (Misu et al., 2007). The transcription levels of a class of genes involved in oxida-
tive phosphorylation mechanisms are consistently lower in diabetics than in controls (Mootha
et al., 2003; Misu et al., 2007). Pathway 173 is MAP00531 Glycosaminoglycan degradation
pathway. It is known that Type II diabetes mellitus also induces an increased urinary
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excretion of total glycosaminoglycans (Juretic´ et al., 2002). Pathway 228 is involved in
Oxidative phosphorylation. It is known to be related to diabetes (Misu et al., 2007; Mootha
et al., 2003, 2004). This pathway is a process of cellular respiration in humans (or in gen-
eral eukaryotes) and contains coregulated genes across different tissues and is related to
insulin/glucose disposal. It is associated with ATP synthesis, a pathway involved in energy
transfer. Pathway 172 is MAP00530 Aminosugars metabolism pathway. Aminosugars (=
glucosamine) have no effect on fasting blood glucose levels, glucose metabolism, or insulin
sensitivity at any oral dose level in healthy subjects, individuals with diabetes, or those with
impaired glucose tolerance (Simon et al., 2011).
7 Discussion
The development of a pathway-based mixed model to relate the response with genetic path-
ways is motivated by the fact that genes always interact with the environmental variables.
Modeling the P-E interaction effect can help in further understanding the biological mecha-
nisms underlying diseases and facilitate the discovery of potential biomarkers. However, no
existing approaches are able to jointly analyze pathways with the environmental variables
when P-E interaction exists.
In this paper, we have addressed a mixed effects model connecting with kernel machine
methods and smoothing spline, so that we can analyze the genetic pathway data with a
continuous clinical outcome when the P-E interaction effect is present in the model. We
demonstrated the application of our method to a pathway data of Type II diabetes. Our
approach allows us to evaluate the pathway effect and its interaction with the environmental
variables by estimating the corresponding variance components and testing the significance
of those parameters. Because of the high dimensional parameters space, there are usually
some difficulties in solving the REML equations, such as non-positive error estimated. We
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reduced the parameter space dimension in solving REML equations by introducing the p-
REML approach to estimate the variance components so that the error component is always
in the parameter space. The p-REML approach not only allows us to solve the REML
equations efficiently, but also provides an efficient choice in testing one or two zero variance
components besides the global score test, i.e. the profile restricted likelihood ratio test for
testing the overall pathway effect or P-E interaction.
Modeling the linear mixed model with a kernel machine has other advantages. It allows
us to choose appropriate kernels to construct the variance matrix of the random effect as well
as the interaction random effect in accordance with the data structure. In this paper, we
focused on the Gaussian kernel, but when the sample size is large so that the computation
becomes expensive, some less computational intensive alternatives to Gaussian kernel are
available, such as rational quadratic kernel: k(zT , z′T ) = 1 − ‖z − z′‖2/(‖z − z′‖2 + c).
Other kernels, such as a polynomial kernel, an exponential kernel, an inverse multiquadric
kernel, etc., have also been examined and can replace the Gaussian kernel in appropriate
situations. Note that these kernels are similar to the Gaussian kernel in terms of reducing the
dimension of the covariates through measuring the similarity of z and z′. To some extent,
this may be a disadvantage of the kernel method since there may be some information lost
beyond the similarity of the two attributes.
Possible extensions of our method include applying the interaction kernel machine to
generalized linear models. Logistic kernel machine regression with a Gaussian kernel has
been developed by Liu et al (2008), but no interaction between the genetic pathway effect and
environmental variable has been considered. By adding the interaction kernel machine to a
generalized linear model, our method can be applied in more general genomewide association
studies, especially in the case-control studies of G/P-E interaction. The second potential
extension of our method is to consider a higher dimension of environmental variables xTi ,
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such as bivariate xTi = (xi1, xi2), longitude and latitude data, and the nonparametric function
fx(x
T
i ) can be fitted using thin plate splines (Gu and Wahba, 1993). With the kernel of the
thin plate splines, we can construct the interaction function space kernel similarly. This
extension may have wider applications such as in spatial data where the interaction between
location and other high dimensional covariates are particularly interesting.
We note that we evaluate the interaction between each pathway and environmental vari-
able. It is known that pathways are not independent of each other because of shared genes
and interactions among pathways as well as their interaction with environmental variables,
making it difficult to adjust the p-value due to the complex dependency structure. Be-
cause existing multiple comparison methods based on false discovery rates (Benjamini and
Hochberg, 1995; Storey, 2002) were developed only for single gene based analysis that did not
take into account the interaction between genes and environmental variables, they are not
applicable in such a complicated situation as our problem. Developing a multiple comparison
method will be an interesting and challenging problem because of the complex dependence
structure among pathways and environmental variables.
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Table 1: Assessments of estimating fx, fz and fxz simulated by (34) using REML and p-
REML procedures with ρ estimated from initial value 2 or fixed at 2. Total runs number
200 for each scenario, and the average values are reported.
fitted p ρˆ fx ∼ fˆx fz ∼ fˆz fxz ∼ fˆxz
n (true p) σˆ2 (initial ρ) Int Slope R2 Int Slope R2 Int Slope R2
100
30(30) 0.34 2130(2) -0.38 1.00 0.97 -0.01 10.51 0.90 -0.14 5.19 0.46
40(30) 0.29 1824(2) -0.55 1.06 0.96 0.01 11.65 0.89 -0.11 4.17 0.50
REML 50(30) 0.32 1929(2) -1.53 1.26 0.96 -0.02 16.07 0.87 -0.13 5.28 0.48
ρ
150
30(30) 0.26 1604(2) -1.15 1.17 0.98 0.09 5.87 0.93 -0.17 3.70 0.54
estimated 40(30) 0.29 1814(2) -0.68 1.18 0.97 -0.09 8.65 0.91 -0.15 3.95 0.48
50(30) 0.35 2054(2) -1.24 1.18 0.97 0.06 12.32 0.90 -0.15 4.79 0.45
100
30(30) 6.9e-10 2 0.10 0.99 0.99 0.01 0.85 0.99 0.01 1.44 0.90
40(30) 8.6e-10 2 0.13 0.98 0.98 0.02 0.86 0.98 0.00 1.40 0.90
REML 50(30) 8.5e-10 2 0.16 0.98 0.96 0.01 0.86 0.98 0.01 1.41 0.88
ρ
150
30(30) 8.5e-10 2 0.05 0.99 0.99 0.01 0.84 0.99 0.01 1.41 0.93
fixed 40(30) 8.7e-10 2 -0.00 1.00 0.99 0.00 0.84 0.99 -0.01 1.40 0.92
50(30) 7.1e-10 2 0.10 0.99 0.99 0.02 0.85 0.99 0.00 1.38 0.91
100
30(30) 0.04 3.96(2) -0.24 1.04 1.00 0.01 0.85 0.99 -0.04 1.38 0.90
40(30) 0.07 3.36(2) -0.19 1.03 1.00 -0.01 0.87 0.99 -0.05 1.46 0.89
p-REML 50(30) 0.09 4.72(2) -0.31 1.04 1.00 0.06 0.90 0.98 -0.04 1.44 0.88
ρ
150
30(30) 0.02 3.00(2) -0.28 1.04 1.00 0.01 0.85 0.99 -0.05 1.29 0.92
estimated 40(30) 0.02 3.63(2) -0.29 1.04 1.00 0.01 0.86 0.99 -0.04 1.29 0.91
50(30) 0.04 3.19(2) -0.13 1.02 1.00 0.01 0.85 0.99 -0.02 1.37 0.91
100
30(30) 0.04 2 -0.08 1.01 1.00 0.02 0.85 0.99 -0.01 1.64 0.91
40(30) 0.11 2 -0.17 1.03 0.99 -0.00 0.88 0.98 -0.03 1.52 0.91
p-REML 50(30) 0.11 2 -0.12 1.02 0.99 -0.00 0.90 0.98 -0.01 1.38 0.91
ρ
150
30(30) 0.02 2 -0.08 1.01 1.00 0.02 0.86 0.99 -0.01 1.34 0.93
fixed 40(30) 0.03 2 -0.11 1.02 1.00 -0.01 0.85 0.99 -0.05 1.37 0.92
50(30) 0.04 2 -0.09 1.01 1.00 0.02 0.86 0.99 -0.02 1.44 0.92
Table 2: Simulation study for RLRT of overall pathway effect with ρ fixed at different values
and estimated. Simulated samples size n = 100, and both used and true gene number equal
to p = 30.
ρ b = 0 0.2 0.35 0.5 1
a = 0
2 0.03 0.34 0.91 1.00 1.00
5 0.02 0.34 0.89 0.99 1.00
10 0.02 0.30 0.88 0.99 1.00
estimated 0.03 0.33 0.87 0.99 1.00
a = 0 0.05 0.1 0.2 0.5
b = 0
2 0.03 0.07 0.37 0.96 1.00
5 0.02 0.07 0.37 0.95 1.00
10 0.02 0.06 0.34 0.91 1.00
estimated 0.03 0.06 0.34 0.93 1.00
Table 3: Simulation study for RLRT of overall pathway effect with fitted genes number p
equal or larger than true one p = 30. Simulated samples size n = 60 and n = 35. The
parameter ρ is fixed at 2.
n used p b = 0 0.2 0.35 0.5 1
a = 0
60
30 0.03 0.18 0.57 0.88 1.00
50 0.03 0.15 0.48 0.76 0.99
35
30 0.04 0.10 0.27 0.46 0.85
50 0.03 0.08 0.23 0.38 0.78
a = 0 0.1 0.2 0.5 1.5
b = 0
60
30 0.03 0.15 0.51 0.72 0.72
50 0.03 0.13 0.41 0.72 0.76
35
30 0.04 0.09 0.25 0.56 0.63
50 0.03 0.05 0.18 0.43 0.55
Table 4: Simulation study for PLRT and score test of P-E interaction with ρ fixed at different
values. Fitted and used gene numbers are equal to p = 5, and n = 100.
ρ b = 0 0.1 0.2 0.35 0.5 0.8 1
2 0.04 0.24 0.58 0.95 1.00 1.00 1.00
RLRT 5 0.04 0.24 0.64 0.98 1.00 1.00 1.00
10 0.03 0.24 0.67 0.97 1.00 1.00 1.00
score 2 0.08 0.31 0.68 0.98 1.00 1.00 1.00
test 5 0.06 0.30 0.72 0.97 1.00 1.00 1.00
10 0.06 0.26 0.72 0.98 1.00 1.00 1.00
Table 5: Estimated parameters of top 20 pathways obtained from p-REML and ranked by
p-values of testing RLRT D. The numbers in the round brackets are the standard errors.
pathway fixed RLRT RLRT
ID gene# βˆ0 βˆ1 σˆ2 τˆx τˆz τˆxz ρ D p-value
73 11 5.09(1.51) -0.01(0.21) 0.08(0.39) 1.0e-11(0.02) 6.09(3.12) 17.7(11.8) 0.457 12.2 0.001
274 16 7.25(1.35) 0.20(0.16) 0.66(0.71) 2.1e-09(0.02) 4.74(3.09) 9.74(8.90) 0.581 7.68 0.006
230 121 5.69(1.39) 0.15(0.14) 0.10(1.03) 7.3e-11(0.02) 5.75(3.42) 6.17(6.99) 0.330 7.81 0.006
229 133 5.82(1.13) 0.15(0.12) 1.29(1.28) 1.7e-03(0.02) 3.25(2.99) 3.96(6.31) 0.289 6.65 0.012
152 11 6.13(1.12) 0.21(0.15) 2.16(0.91) 8.6e-09(0.02) 1.57(2.21) 7.48(8.69) 1.266 6.20 0.014
16 49 5.76(1.00) 0.14(0.13) 1.98(1.24) 1.5e-08(0.02) 1.89(2.55) 4.57(6.82) 0.308 5.93 0.017
173 11 6.06(1.07) 0.19(0.15) 2.14(0.92) 2.1e-09(0.01) 1.57(2.22) 7.10(7.93) 0.756 5.77 0.017
236 22 6.27(1.06) 0.23(0.15) 2.10(1.06) 1.4e-08(0.02) 1.41(2.24) 7.24(8.08) 0.862 5.63 0.019
144 7 5.43(1.21) 0.15(0.20) 2.35(0.85) 1.6e-03(0.02) 1.16(2.26) 11.5(11.7) 0.411 5.35 0.019
151 20 6.08(1.04) 0.22(0.14) 2.15(1.06) 7.5e-09(0.02) 1.52(2.24) 6.21(7.51) 0.937 5.62 0.019
14 49 6.09(1.20) 0.16(0.14) 1.57(1.27) 1.3e-09(0.02) 2.76(2.91) 5.72(7.42) 0.706 5.30 0.024
228 43 6.16(0.77) 0.20(0.14) 2.88(1.18) 7.4e-11(0.02) 0.03(1.73) 5.91(6.86) 0.374 4.95 0.028
103 37 6.09(0.90) 0.20(0.14) 2.58(1.20) 9.8e-09(0.02) 0.74(2.08) 5.76(7.42) 0.751 4.82 0.030
271 37 6.20(0.92) 0.22(0.14) 2.45(1.23) 7.5e-12(0.02) 0.94(2.19) 5.73(7.19) 0.702 4.83 0.030
150 21 5.98(0.94) 0.19(0.14) 2.54(1.12) 7.5e-11(0.02) 0.97(2.10) 5.75(7.65) 1.161 4.66 0.033
172 8 5.85(0.92) 0.15(0.18) 2.75(0.99) 2.6e-03(0.02) 3.5e-10(1.61) 10.1(9.8) 0.812 4.22 0.039
133 58 6.01(0.83) 0.18(0.14) 2.71(1.29) 1.8e-03(0.02) 0.32(2.04) 6.28(7.18) 0.339 4.15 0.044
8 27 5.87(0.78) 0.18(0.15) 2.92(1.15) 1.6e-02(0.04) 3.0e-09(1.72) 5.96(7.21) 0.527 4.08 0.045
101 13 6.08(0.90) 0.19(0.16) 3.01(1.01) 5.7e-10(0.02) 0.23(1.59) 6.81(8.79) 0.458 3.88 0.045
158 8 5.79(1.00) 0.15(0.14) 2.55(0.98) 1.3e-09(0.02) 1.55(2.24) 5.39(7.72) 0.621 3.53 0.056
Table 6: P-values of different tests for top 20 pathway significant in the overall pathway
effect. Columns 2 and 3 are labels indicating appearance in the top 50 list of other methods
or not. Missing values in column 6 is because the information matrix is not positive definite.
pathway Global Forest RLRT permutation RLRT permutation score test
ID Score Test Tree test for D test for D test for d test for d for Uτxz
73 Yes Yes 0.001 0.001 0.002 0.001 0.005
274 Yes No 0.006 0.011 0.025 0.013 0.016
230 Yes Yes 0.006 0.010 - 0.025 0.007
229 Yes Yes 0.012 0.020 - 0.138 0.062
152 No No 0.014 0.015 0.179 0.303 0.163
16 Yes Yes 0.017 0.027 0.126 0.147 0.058
173 Yes Yes 0.017 0.020 0.017 0.018 0.002
236 No No 0.019 0.021 0.133 0.119 0.104
144 Yes Yes 0.019 0.020 0.076 0.072 0.106
151 No No 0.019 0.023 0.205 0.262 0.146
14 Yes No 0.024 0.031 0.113 0.054 0.046
228 Yes Yes 0.028 0.035 0.032 0.024 0.006
103 No Yes 0.030 0.039 0.121 0.106 0.086
271 No No 0.030 0.037 0.148 0.142 0.110
150 No No 0.033 0.034 0.080 0.062 0.044
172 No No 0.039 0.044 0.016 0.015 0.009
133 No No 0.044 0.057 0.053 0.043 0.018
8 Yes Yes 0.045 0.052 0.051 0.038 0.032
101 No No 0.045 0.044 0.068 0.049 0.056
158 Yes No 0.056 0.054 - 0.343 0.560
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Figure 1: Diagram of the parameter space of RLRT for testing two zero variance components
(a), and testing the P-E interaction effect (b).
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Figure 2: Selected example of fitting results of setting 1. Because of the high dimensionality,
rz, rxz and f are plotted vs. the observation index only.
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Figure 3: The estimated variance components of σˆ2, τˆx, τˆz, τˆxz for 251 pathways ordered by
p-values of testing the overall pathway effect. The dash lines separate the significant and
insignificant pathways at 5% level.
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Figure 4: The p-values of testing overall pathway effect (RLRT D) and P-E interaction effect
(RLRT d) for 251 pathways. The vertical dash line divides the significant and insignificant
pathways of overall pathway effect test, and the horizontal dash line indicates 5% significant
level. Some p-values of RLRT d are missing because the information matrix is not positive
definite.
Appendix A The Representation of the Natural Cubic
Spline
Following Green and Silverman (1994), the representation of the natural cubic spline (8) in
section 2.2 is called the value-second derivative representation. Details for defining matrices
B and M are shown as the following.
Suppose fx is the natural cubic spline with n distinct x
0
1 <, ..., < x
0
n. Define
fx,i = fx(x
0
i ) and γi = f
′′
x (x
0
i ) for i = 1, ..., n
By the definition of natural cubic spline, γ1 = γn = 0. Let fx stands for the vector
(fx,1, ..., fx,n)
T and let γ = (γ2, ..., γn−1)T where γ is a (n − 2) × 1 vector with the ele-
ment index starting at i = 2. Now define two matrices, Q and R. Let hi = ti+1 − ti for
i = 1, ..., n − 1. Let Q be the n × (n − 2) matrix with entries qij, for i = 1, ..., n − 1 and
j = 2, ..., n− 1, given by
qj−1,j = h−1j−1, qjj = −h−1j−1 − h−1j , and qj+1,j = h−1j (35)
for j = 2, ..., n − 1 and qij = 0 for |i − j| ≥ 2. The columns of Q are indexed in the same
way as the elements of γ starting at j = 2, so that the first element of Q is q12.
R is a (n− 2)× (n− 2) symmetric matrix with elements rij, for i and j running from 2
to n− 1, given by
rii =
1
3
(hi−1 + hi) for i = 2, ..., n− 1,
ri,i+1 = ri+1,i =
1
6
hi for i = 2, ..., n− 2,
(36)
and rij = 0 for |i− j| ≥ 2.
The matrix R is strictly diagonal dominant and strictly positive definite. Using the
Cholesky factorization that avoids taking the square roots (Green and Silverman, 1994)
Section 2.6.1, we can factorize R as
R = UΛUT ,
where Λ is a diagonal matrix and U is a lower triangular band matrix with diagonal elements
all equal to 1. Since R are strictly positive definite, all diagonal elements of Λ are positive,
R−1 = (Λ1/2UT )−1(UΛ1/2)−1. The penalty matrix M can be expressed as
M = QR−1QT = Q(Λ1/2UT )−1(UΛ1/2)−1QT = LLT , (37)
where L = Q(Λ1/2UT )−1. The B matrix thus is calculated by
B = L(LTL)−1 = Q(Λ1/2UT )−1
{
[(Λ1/2UT )−1]TQTQ(Λ1/2UT )−1
}−1
= Q(Λ1/2UT )−1(Λ1/2UT )(QTQ)−1(Λ1/2UT )T
= Q(QTQ)−1UΛ1/2.
The Theorem 2.1 in Green and Silverman (1994) states that the vectors fx and γ specific a
natural cubic spline fx if and only if the condition Q
T fx = Rγ is satisfied. If this condition
is satisfied then the roughness penalty will satisfy∫ 1
0
{f ′′x (x)}2dx =
n−1∑
j=1
γj+1 − γj
hj
(fx,j − fx,j+1) = γTQT fx
= γTRγ = fTx QR
−1QT fx = fxM fx.
In the above derivation we assumed that x0i , i = 1, ..., n, were distinct and ordered, so the
rank of the penalty matrix M is n − 2 and B is a n × (n − 2) matrix. In our model, we
shall have r distinct and ordered x0i , i = 1, ..., r, from the observed data xi, i = 1, ..., n, where
r ≤ n and xi’s may not be ordered. Based the r x0i ’s, B is a r × (r − 2) matrix. Thus we
will use a n × r incidence matrix N defined in a way similar to that given by Green and
Silverman (1994), Section 4.3.1, such that B = NB, where the left B is what we shall use
in the model, and the right B is calculated based on r distinct x0i ’s.
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